Rupix

Amanta Healthcare IPO

Amanta Healthcare came to market through an IPO that opened on 1 September 2025 and closed on 3 September 2025, and the shares listed on 9 September 2025 on BSE, NSE. The price band was ₹120 to ₹126 per share and one lot was 119 shares, so the minimum application was ₹14,994. The issue size was ₹126 crore. The whole issue was fresh shares, so the money raised went to the company.

MUFG Intime India Pvt Ltd was the registrar to the issue, and Beeline Capital Advisors Pvt Ltd was the lead manager.

Issue details

Issue type
Book Built Issue
Price band
₹120 to ₹126
Lot size
119 shares
Minimum investment
₹14,994
Face value
₹10 per share
Issue size
₹126 crore
Fresh issue
1,00,00,000 shares (aggregating up to ₹126 crore)
Listing at
BSE, NSE
Registrar
MUFG Intime India Pvt Ltd
Lead managers
Beeline Capital Advisors Pvt Ltd
Promoter holding before the issue
85.60%
Promoter holding after the issue
63.56%

Timeline

Opens
1 September 2025
Closes
3 September 2025
Allotment
4 September 2025
Listing
9 September 2025

Subscription status by day

As of 3 September 2025.

Day
1
2
3

Listing day and after

Issue price
₹126
Listed on
9 September 2025

About Amanta Healthcare

Established in December 1994, Amanta Healthcare Limited is a pharma firm that focuses on the manufacturing, development, and marketing of a wide range of sterile liquid items, namely parenteral items, packaged in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company also engages in the manufacturing of medical devices.The company produces formulations for fluid therapy, such as IV fluids, diluents, ophthalmic solutions, and respiratory care products.

The company also sells irrigation solutions, first-aid items, and eye lubricants in the medical device market. The company sells products through three business divisions: National sales International sales Product partnering with several foreign and Indian pharma companies. The company produces more than 45 generic items, selling them under their brand names in India through 320 stockists and distributors.The firm markets products in Africa, Latin America, the UK, and overseas.

It has registered its products in 19 countries and meets numerous regulations. During Fiscal 2025, the firm shipped branded goods to 21 countries. As of March 31, 2025, the firm employs a workforce of 1,718 at its formulation and development and quality laboratory.

As described in the offer document.

Objects of the issue

  • Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
  • Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat
  • General corporate purposes

Strengths

  • Established in 1994 with diversified pharmaceutical product portfolio
  • Advanced sterile liquid manufacturing across wide volume range
  • Certified facility with ISO, WHO-GMP, and advanced technologies
  • Experienced leadership with skilled, qualified employee base

Risks

  • High customer concentration poses revenue stability and dependency risks
  • Delay in SteriPort/SVP expansion may impact growth plans
  • Sterile liquid products carry serious product liability exposure
  • Unsecured borrowings and personal guarantees increase financial vulnerability

Financials (₹ crore)

Metric31-Mar-2531-Mar-2431-Mar-23

Listed peers

Amanta Healthcare
RoNW 10.9%%
Denis Chem
RoNW 9.77%%

Amanta Healthcare raises Rs 37.8 crore from anchor investors before Rs 126-crore IPO. Out Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and FinavenueFund came through its Small Cap Fund.Sanshi Fund, Perpetuity Health to Wealth Rising Fund, Sunrise Investment Trust, and Finavenue Capital Trust were some other institutional investors that came on board for the anchor book.

Promoters

Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, Milcent Appliances Private Limited. Promoter holding 85.60% before the issue and 63.56% after.

Application sizes

Retail (min)
1 lot, 119 shares, ₹14,994
Retail(max)
13 lots, 1547 shares, ₹1,94,922
sHNI(min)
14 lots, 1666 shares, ₹2,09,916
sHNI(max)
66 lots, 7854 shares, ₹9,89,604
bHNI(min)
67 lots, 7973 shares, ₹10,04,598

Valuation

EPS Pre IPO
₹3.64
EPS Post IPO
₹2.70
P/E Pre IPO
34.59
P/E Post IPO
46.59
ROE
12.42%
ROCE
13.72%
RoNW
10.89%
PAT Margin
3.86%
Debt/Equity
2.02
Price/Book
3.77

Registrar and allotment status

Registrar
MUFG Intime India Pvt Ltd
Allotment status
https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Phone
+91-22-4918 6270
Email
amantahealthcare.ipo@linkintime.co.in

Work out the listing gain for this IPO

How allotment works

If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.

The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.

Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.

What happens on listing day

Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.

For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.

Questions about the Amanta Healthcare IPO

What is Amanta Healthcare IPO?

Amanta Healthcare IPO was a ₹126 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹120–₹126 per share with a lot size of 119 shares (₹14,994). The IPO was open from September 1 to September 3, 2025 and was subscribed 82.61x. Shares listed on BSE and NSE on September 9, 2025 at ₹135, a 7.1% premium to the issue price of ₹126. MUFG Intime India Pvt Ltd is the registrar.

Beeline Capital Advisors Pvt Ltd is the book running lead manager.

What is the price band of Amanta Healthcare IPO?

The price band of Amanta Healthcare IPO is ₹120 to ₹126 per share.

What is the lot size of Amanta Healthcare IPO?

The lot size of Amanta Healthcare IPO is 119 shares.

What is the minimum investment for Amanta Healthcare IPO?

The minimum investment for Amanta Healthcare IPO is approximately ₹14,994 based on the upper price band.

What is the allotment date of Amanta Healthcare IPO?

The allotment date of Amanta Healthcare IPO is Sep 4, 2025.

What was the GMP of Amanta Healthcare IPO before listing?

Amanta Healthcare IPO's final recorded GMP before listing was ₹8 per share (a 6% premium over the ₹126 upper price band). The shares listed at ₹135. GMP is unofficial and does not forecast or guarantee the actual listing price.

How has Amanta Healthcare IPO share price performed since listing?

Amanta Healthcare IPO listed on Sep 9, 2025. It was issued at ₹135.0(NSE) and is currently around ₹164.79 as on 30-Oct-2026 3:30 PM, which is approximately 30.8% versus issue price. The 52-week high is ₹209.95.

How to check Amanta Healthcare IPO allotment status?

You can check Amanta Healthcare IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Amanta Healthcare IPO allotment status on Rupix for quick and easy access.

What was the price band of the Amanta Healthcare IPO?

₹120 to ₹126 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.

What was the lot size of the Amanta Healthcare IPO?

One lot was 119 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,994.

What was the minimum investment in the Amanta Healthcare IPO?

₹14,994, for one lot of 119 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.

When did the Amanta Healthcare IPO open and close?

It opened on 1 September 2025 and closed on 3 September 2025.

When was the allotment of the Amanta Healthcare IPO?

The basis of allotment was published on 4 September 2025 by MUFG Intime India Pvt Ltd, and allotted shares were credited to demat accounts before listing.

When did Amanta Healthcare list on BSE, NSE?

The shares listed on 9 September 2025 on BSE, NSE.

How large was the Amanta Healthcare IPO?

The issue size was ₹126 crore. The fresh issue was 1,00,00,000 shares (aggregating up to ₹126 crore).